Swedbank
GILD icon

Swedbank’s Gilead Sciences GILD Stock Holding History

Swedbank’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$240M Sell
1,903,177
-494,823
-21% -$65.2M 0.21% 83
2026
Q1 		$334M Sell
2,398,000
-107,240
-4% -$15M 0.35% 58
2025
Q4 		$307M Buy
2,505,240
+43,205
+2% +$5.25M 0.3% 71
2025
Q3 		$273M Buy
2,462,035
+58,405
+2% +$6.64M 0.28% 81
2025
Q2 		$266M Buy
2,403,630
+284,998
+13% +$30.3M 0.3% 76
2025
Q1 		$237M Buy
2,118,632
+16,663
+0.8% +$1.72M 0.32% 70
2024
Q4 		$194M Buy
2,101,969
+54,360
+3% +$4.89M 0.24% 87
2024
Q3 		$172M Buy
2,047,609
+189,622
+10% +$14.5M 0.22% 91
2024
Q2 		$127M Buy
+1,857,987
New +$124M 0.17% 105
2024
Q1 		– Sell
-1,660,410
Closed -$135M – 632
2023
Q4 		$135M Sell
1,660,410
-13,646
-0.8% -$1.06M 0.22% 92
2023
Q3 		$125M Sell
1,674,056
-50,198
-3% -$3.86M 0.22% 87
2023
Q2 		$133M Buy
1,724,254
+3,358
+0.2% +$268K 0.23% 90
2023
Q1 		$143M Sell
1,720,896
-94,033
-5% -$7.79M 0.28% 75
2022
Q4 		$156M Buy
1,814,929
+49,511
+3% +$3.92M 0.34% 64
2022
Q3 		$109M Buy
1,765,418
+7,557
+0.4% +$477K 0.26% 85
2022
Q2 		$109M Sell
1,757,861
-49,185
-3% -$3.05M 0.25% 87
2022
Q1 		$107M Buy
1,807,046
+2,896
+0.2% +$185K 0.2% 108
2021
Q4 		$132M Sell
1,804,150
-47,210
-3% -$3.25M 0.22% 102
2021
Q3 		$129M Sell
1,851,360
-127,402
-6% -$8.95M 0.24% 90
2021
Q2 		$136M Sell
1,978,762
-458,115
-19% -$30.6M 0.26% 79
2021
Q1 		$157M Sell
2,436,877
-206,052
-8% -$13.3M 0.33% 66
2020
Q4 		$150M Sell
2,642,929
-120,802
-4% -$7.29M 0.44% 66
2020
Q3 		$175M Buy
2,763,731
+878
+0% +$60.9K 0.6% 47
2020
Q2 		$213M Sell
2,762,853
-1,387,052
-33% -$106M 0.77% 32
2020
Q1 		$310M Buy
4,149,905
+82,525
+2% +$5.7M 1.53% 16
2019
Q4 		$264M Sell
4,067,380
-392,266
-9% -$25.5M 1.07% 24
2019
Q3 		$283M Buy
4,459,646
+529,744
+13% +$34.6M 1.29% 21
2019
Q2 		$266M Sell
3,929,902
-44,939
-1% -$2.96M 1.2% 20
2019
Q1 		$258M Sell
3,974,841
-383,579
-9% -$25.5M 1.23% 24
2018
Q4 		$270M Buy
4,358,420
+452,248
+12% +$31.6M 1.48% 17
2018
Q3 		$302M Buy
3,906,172
+1,988,987
+104% +$150M 1.35% 19
2018
Q2 		$136M Sell
1,917,185
-13,734
-0.7% -$970K 0.67% 50
2018
Q1 		$146M Buy
1,930,919
+560
+0% +$44.5K 0.76% 46
2017
Q4 		$138M Buy
1,930,359
+143,525
+8% +$10.9M 0.75% 46
2017
Q3 		$145M Sell
1,786,834
-428,125
-19% -$32.7M 0.89% 38
2017
Q2 		$157M Buy
2,214,959
+9,857
+0.4% +$656K 1.05% 36
2017
Q1 		$150M Sell
2,205,102
-394,660
-15% -$27.8M 1.06% 36
2016
Q4 		$186M Sell
2,599,762
-834,669
-24% -$62M 1.47% 26
2016
Q3 		$272M Sell
3,434,431
-882,970
-20% -$71.7M 2.23% 18
2016
Q2 		$360M Buy
4,317,401
+834
+0% +$74K 3.04% 9
2016
Q1 		$397M Buy
4,316,567
+308,169
+8% +$27.8M 3.22% 9
2015
Q4 		$409M Buy
4,008,398
+444,063
+12% +$46.2M 3.22% 8
2015
Q3 		$350M Sell
3,564,335
-49,399
-1% -$5.49M 2.9% 10
2015
Q2 		$423M Buy
3,613,734
+280,612
+8% +$30.7M 3.11% 8
2015
Q1 		$327M Sell
3,333,122
-686,294
-17% -$69.7M 2.55% 11
2014
Q4 		$379M Buy
+4,019,416
New +$416M 2.92% 9
2014
Q1 		$327M Buy
+3,333,122
New +$261M 2.55% 11

Other funds holding GILD

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
OIAM
OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return
P
PensionDanmark Copenhagen O, Denmark $12B AUM

Swedbank's GILD Position: Q2 2026 in Review

Swedbank reduced its Gilead Sciences (GILD) stake by 21% in Q2 2026, selling an estimated $65.2M and leaving 1,903,177 shares worth $240M. The position accounts for 0.21% of the portfolio, ranked #83.

Swedbank first reported a position in GILD in Q1 2014 and has held it in 47 quarters since. The position peaked at $423M in Q2 2015. 349 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Swedbank held 1,903,177 shares of Gilead Sciences worth $240M as of Q2 2026.
  • Swedbank sold 494,823 Gilead Sciences shares in Q2 2026, an estimated $65.2M.
  • Gilead Sciences made up 0.21% of Swedbank's portfolio in Q2 2026, its #83 holding.
  • Swedbank first reported a position in Gilead Sciences in Q1 2014 and has held it in 47 quarters since.
  • Swedbank's Gilead Sciences position peaked at $423M in Q2 2015.
  • 349 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Swedbank's 13F filing for Q2 2026, filed 15 Jul 2026.